LISI GROUP - Integrated report 2022

2022 was a year of ramp-up in many market segments. Growth has accelerated, demand is well oriented and the level of order books remains high. After the years of health crisis, the momentum brought by the recovery constitutes a positive and structuring factor, for the division and for all the teams.” – Emmanuel Neildez CEO, LISI AEROSPACE The medical industry has regained a fairly clear dynamic. The division was driven by the development of new products for our customers, with a significant ramp-up in production volumes across our sites, in France and in the United States. We have also managed to implement simultaneous development operations for the same client on both sides of the Atlantic... Something unprecedented!” – Lionel Rivet CEO, LISI MEDICAL In an automotive market that remained constrained in 2022, the division performed well, with organic growth much higher than that of the market. The recent commercial successes that we have encountered, as well as the arrival of new products with high added value, point to encouraging prospects for the division.” – François Liotard CEO, LISI AUTOMOTIVE 57 LISI – 2022 INTEGRATED REPORT